| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.935 | 0.003 | 0.935 | Bronchodilator | 0.935 0.003 DBMET03275 0.935 0.003 DBMET03276 | ||
| 0.883 | 0.004 | 0.883 | Antiadrenergic | 0.883 0.004 DBMET03275 0.883 0.004 DBMET03276 | ||
| 0.883 | 0.004 | 0.883 | Adrenaline antagonist | 0.883 0.004 DBMET03275 0.883 0.004 DBMET03276 | ||
| 0.827 | 0.004 | 0.827 | Spasmolytic | 0.827 0.004 DBMET03275 0.827 0.004 DBMET03276 | ||
| 0.813 | 0.005 | 0.813 | Antiobesity | 0.813 0.005 DBMET03275 0.813 0.005 DBMET03276 | ||
| 0.738 | 0.007 | 0.738 | Toll-Like receptor 7 agonist | 0.738 0.007 DBMET03275 0.738 0.007 DBMET03276 | ||
| 0.735 | 0.007 | 0.735 | Toll-Like receptor agonist | 0.735 0.007 DBMET03275 0.735 0.007 DBMET03276 | ||
| 0.71 | 0.005 | 0.71 | Vasodilator, peripheral | 0.71 0.005 DBMET03275 0.71 0.005 DBMET03276 | ||
| 0.705 | 0.014 | 0.705 | Cyclophilin D inhibitor | 0.705 0.014 DBMET03275 0.705 0.014 DBMET03276 | ||
| 0.673 | 0.003 | 0.673 | Calcium channel L-type activator | 0.673 0.003 DBMET03275 0.673 0.003 DBMET03276 | ||
| 0.605 | 0.008 | 0.605 | Cardiotonic | 0.605 0.008 DBMET03275 0.605 0.008 DBMET03276 | ||
| 0.594 | 0.006 | 0.594 | Psychostimulant | 0.594 0.006 DBMET03275 0.594 0.006 DBMET03276 | ||
| 0.595 | 0.008 | 0.595 | Vasodilator, coronary | 0.595 0.008 DBMET03275 0.595 0.008 DBMET03276 | ||
| 0.576 | 0.005 | 0.576 | Peroxidase inhibitor | 0.576 0.005 DBMET03275 0.576 0.005 DBMET03276 | ||
| 0.543 | 0.006 | 0.543 | Interleukin agonist | 0.543 0.006 DBMET03275 0.543 0.006 DBMET03276 | ||
| 0.511 | 0.002 | 0.511 | Adrenaline agonist | 0.511 0.002 DBMET03275 0.511 0.002 DBMET03276 | ||
| 0.512 | 0.011 | 0.512 | Vasodilator | 0.512 0.011 DBMET03275 0.512 0.011 DBMET03276 | ||
| 0.512 | 0.013 | 0.512 | Hypoxia-inducible factor 1 alpha inhibitor | 0.512 0.013 DBMET03275 0.512 0.013 DBMET03276 | ||
| 0.497 | 0.002 | 0.497 | Beta adrenoreceptor antagonist | 0.497 0.002 DBMET03275 0.497 0.002 DBMET03276 | ||
| 0.497 | 0.002 | 0.497 | Phenylalanine 4-hydroxylase inhibitor | 0.497 0.002 DBMET03275 0.497 0.002 DBMET03276 | ||
| 0.49 | 0.004 | 0.49 | Anesthetic local | 0.49 0.004 DBMET03275 0.49 0.004 DBMET03276 | ||
| 0.512 | 0.043 | 0.512 | Transcription factor NF kappa B inhibitor | 0.512 0.043 DBMET03275 0.512 0.043 DBMET03276 | ||
| 0.471 | 0.002 | 0.471 | Beta 2 adrenoreceptor antagonist | 0.471 0.002 DBMET03275 0.471 0.002 DBMET03276 | ||
| 0.487 | 0.035 | 0.487 | Aldehyde oxidase inhibitor | 0.487 0.035 DBMET03275 0.487 0.035 DBMET03276 | ||
| 0.481 | 0.036 | 0.481 | Histamine release inhibitor | 0.481 0.036 DBMET03275 0.481 0.036 DBMET03276 | ||
| 0.439 | 0.013 | 0.439 | Calcium channel activator | 0.439 0.013 DBMET03275 0.439 0.013 DBMET03276 | ||
| 0.404 | 0.008 | 0.404 | Tyrosine 3 hydroxylase inhibitor | 0.404 0.008 DBMET03275 0.404 0.008 DBMET03276 | ||
| 0.396 | 0.002 | 0.396 | Beta 3 adrenoreceptor antagonist | 0.396 0.002 DBMET03275 0.396 0.002 DBMET03276 | ||
| 0.432 | 0.042 | 0.432 | Antithrombotic | 0.432 0.042 DBMET03275 0.432 0.042 DBMET03276 | ||
| 0.39 | 0.002 | 0.39 | Beta 1 adrenoreceptor antagonist | 0.39 0.002 DBMET03275 0.39 0.002 DBMET03276 | ||
| 0.388 | 0.005 | 0.388 | Expectorant | 0.388 0.005 DBMET03275 0.388 0.005 DBMET03276 | ||
| 0.43 | 0.049 | 0.43 | GABA C receptor rho-3 antagonist | 0.43 0.049 DBMET03275 0.43 0.049 DBMET03276 | ||
| 0.367 | 0.002 | 0.367 | Beta adrenoreceptor agonist | 0.367 0.002 DBMET03275 0.367 0.002 DBMET03276 | ||
| 0.369 | 0.009 | 0.369 | Peptidyltransferase inhibitor | 0.369 0.009 DBMET03275 0.369 0.009 DBMET03276 | ||
| 0.349 | 0.004 | 0.349 | Mucolytic | 0.349 0.004 DBMET03275 0.349 0.004 DBMET03276 | ||
| 0.346 | 0.002 | 0.346 | Adenylate cyclase stimulant | 0.346 0.002 DBMET03275 0.346 0.002 DBMET03276 | ||
| 0.346 | 0.003 | 0.346 | Glutamate decarboxylase inhibitor | 0.346 0.003 DBMET03275 0.346 0.003 DBMET03276 | ||
| 0.374 | 0.034 | 0.374 | Free radical scavenger | 0.374 0.034 DBMET03275 0.374 0.034 DBMET03276 | ||
| 0.341 | 0.005 | 0.341 | Nitric-oxide synthase stimulant | 0.341 0.005 DBMET03275 0.341 0.005 DBMET03276 | ||
| 0.315 | 0.002 | 0.315 | Calcium-sensing receptor antagonist | 0.315 0.002 DBMET03275 0.315 0.002 DBMET03276 | ||
| 0.38 | 0.072 | 0.38 | Calpain 2 inhibitor | 0.38 0.072 DBMET03275 0.38 0.072 DBMET03276 | ||
| 0.353 | 0.046 | 0.353 | Antioxidant | 0.353 0.046 DBMET03275 0.353 0.046 DBMET03276 | ||
| 0.365 | 0.059 | 0.365 | Cholesterol antagonist | 0.365 0.059 DBMET03275 0.365 0.059 DBMET03276 | ||
| 0.353 | 0.056 | 0.353 | 5 Hydroxytryptamine release stimulant | 0.353 0.056 DBMET03275 0.353 0.056 DBMET03276 | ||
| 0.384 | 0.088 | 0.384 | 5 Hydroxytryptamine release inhibitor | 0.384 0.088 DBMET03275 0.384 0.088 DBMET03276 | ||
| 0.332 | 0.042 | 0.332 | Hypoglycemic | 0.332 0.042 DBMET03275 0.332 0.042 DBMET03276 | ||
| 0.337 | 0.048 | 0.337 | Sodium/bile acid cotransporter inhibitor | 0.337 0.048 DBMET03275 0.337 0.048 DBMET03276 | ||
| 0.395 | 0.114 | 0.395 | Caspase 9 stimulant | 0.395 0.114 DBMET03275 0.395 0.114 DBMET03276 | ||
| 0.32 | 0.044 | 0.32 | Interleukin antagonist | 0.32 0.044 DBMET03275 0.32 0.044 DBMET03276 | ||
| 0.289 | 0.018 | 0.289 | Insulin sensitizer | 0.289 0.018 DBMET03275 0.289 0.018 DBMET03276 | ||
| 0.281 | 0.016 | 0.281 | Cholinergic antagonist | 0.281 0.016 DBMET03275 0.281 0.016 DBMET03276 | ||
| 0.274 | 0.016 | 0.274 | Acetylcholine antagonist | 0.274 0.016 DBMET03275 0.274 0.016 DBMET03276 | ||
| 0.258 | 0.002 | 0.258 | Beta 2 adrenoreceptor agonist | 0.258 0.002 DBMET03275 0.258 0.002 DBMET03276 | ||
| 0.281 | 0.03 | 0.281 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.281 0.03 DBMET03275 0.281 0.03 DBMET03276 | ||
| 0.297 | 0.052 | 0.297 | Superoxide dismutase inhibitor | 0.297 0.052 DBMET03275 0.297 0.052 DBMET03276 | ||
| 0.263 | 0.018 | 0.263 | M18 aspartyl aminopeptidase inhibitor | 0.263 0.018 DBMET03275 0.263 0.018 DBMET03276 | ||
| 0.261 | 0.021 | 0.261 | Alpha-N-acetylglucosaminidase inhibitor | 0.261 0.021 DBMET03275 0.261 0.021 DBMET03276 | ||
| 0.303 | 0.072 | 0.303 | Interleukin 2 agonist | 0.303 0.072 DBMET03275 0.303 0.072 DBMET03276 | ||
| 0.254 | 0.024 | 0.254 | Acetylcholine M1 receptor antagonist | 0.254 0.024 DBMET03275 0.254 0.024 DBMET03276 | ||
| 0.226 | 0.005 | 0.226 | Acetylcholine M3 receptor antagonist | 0.226 0.005 DBMET03275 0.226 0.005 DBMET03276 | ||
| 0.234 | 0.017 | 0.234 | Acetylcholine muscarinic antagonist | 0.234 0.017 DBMET03275 0.234 0.017 DBMET03276 | ||
| 0.205 | 0.002 | 0.205 | Beta 1 adrenoreceptor agonist | 0.205 0.002 DBMET03275 0.205 0.002 DBMET03276 | ||
| 0.234 | 0.031 | 0.234 | Melanin inhibitor | 0.234 0.031 DBMET03275 0.234 0.031 DBMET03276 | ||
| 0.226 | 0.027 | 0.226 | Monophenol monooxygenase inhibitor | 0.226 0.027 DBMET03275 0.226 0.027 DBMET03276 | ||
| 0.197 | 0.004 | 0.197 | Anabolic | 0.197 0.004 DBMET03275 0.197 0.004 DBMET03276 | ||
| 0.262 | 0.07 | 0.262 | 5 Hydroxytryptamine uptake stimulant | 0.262 0.07 DBMET03275 0.262 0.07 DBMET03276 | ||
| 0.213 | 0.023 | 0.213 | Adenylate cyclase inhibitor | 0.213 0.023 DBMET03275 0.213 0.023 DBMET03276 | ||
| 0.197 | 0.013 | 0.197 | Histidine decarboxylase inhibitor | 0.197 0.013 DBMET03275 0.197 0.013 DBMET03276 | ||
| 0.195 | 0.011 | 0.195 | Aminoacyl-tRNA synthetase inhibitor | 0.195 0.011 DBMET03275 0.195 0.011 DBMET03276 | ||
| 0.193 | 0.012 | 0.193 | Creatine kinase inhibitor | 0.193 0.012 DBMET03275 0.193 0.012 DBMET03276 | ||
| 0.183 | 0.002 | 0.183 | Beta 3 adrenoreceptor agonist | 0.183 0.002 DBMET03275 0.183 0.002 DBMET03276 | ||
| 0.23 | 0.051 | 0.23 | Neurotrophic factor enhancer | 0.23 0.051 DBMET03275 0.23 0.051 DBMET03276 | ||
| 0.246 | 0.068 | 0.246 | Calpain inhibitor | 0.246 0.068 DBMET03275 0.246 0.068 DBMET03276 | ||
| 0.182 | 0.008 | 0.182 | Carbonic anhydrase stimulant | 0.182 0.008 DBMET03275 0.182 0.008 DBMET03276 | ||
| 0.292 | 0.12 | 0.292 | Immunosuppressant | 0.292 0.12 DBMET03275 0.292 0.12 DBMET03276 | ||
| 0.243 | 0.074 | 0.243 | Antiamyloidogenic | 0.243 0.074 DBMET03275 0.243 0.074 DBMET03276 | ||
| 0.192 | 0.025 | 0.192 | Interleukin 4 antagonist | 0.192 0.025 DBMET03275 0.192 0.025 DBMET03276 | ||
| 0.212 | 0.054 | 0.212 | Growth hormone agonist | 0.212 0.054 DBMET03275 0.212 0.054 DBMET03276 | ||
| 0.168 | 0.013 | 0.168 | Alpha adrenoreceptor agonist | 0.168 0.013 DBMET03275 0.168 0.013 DBMET03276 | ||
| 0.198 | 0.045 | 0.198 | Amylase inhibitor | 0.198 0.045 DBMET03275 0.198 0.045 DBMET03276 | ||
| 0.174 | 0.023 | 0.174 | Pregnane X receptor agonist | 0.174 0.023 DBMET03275 0.174 0.023 DBMET03276 | ||
| 0.227 | 0.079 | 0.227 | Hypolipemic | 0.227 0.079 DBMET03275 0.227 0.079 DBMET03276 | ||
| 0.165 | 0.019 | 0.165 | Sphingomyelinase inhibitor | 0.165 0.019 DBMET03275 0.165 0.019 DBMET03276 | ||
| 0.161 | 0.016 | 0.161 | DOPA decarboxylase inhibitor | 0.161 0.016 DBMET03275 0.161 0.016 DBMET03276 | ||
| 0.222 | 0.079 | 0.222 | Cyclic AMP phosphodiesterase inhibitor | 0.222 0.079 DBMET03275 0.222 0.079 DBMET03276 | ||
| 0.186 | 0.051 | 0.186 | ATPase inhibitor | 0.186 0.051 DBMET03275 0.186 0.051 DBMET03276 | ||
| 0.234 | 0.103 | 0.234 | Immunostimulant | 0.234 0.103 DBMET03275 0.234 0.103 DBMET03276 | ||
| 0.222 | 0.092 | 0.222 | DNA synthesis inhibitor | 0.222 0.092 DBMET03275 0.222 0.092 DBMET03276 | ||
| 0.148 | 0.022 | 0.148 | Electron transport complex I inhibitor | 0.148 0.022 DBMET03275 0.148 0.022 DBMET03276 | ||
| 0.165 | 0.039 | 0.165 | Nav1.3 sodium channel blocker | 0.165 0.039 DBMET03275 0.165 0.039 DBMET03276 | ||
| 0.123 | 0.006 | 0.123 | Gonadotropin-releasing hormone receptor agonist | 0.123 0.006 DBMET03275 0.123 0.006 DBMET03276 | ||
| 0.158 | 0.041 | 0.158 | Cholesterol synthesis inhibitor | 0.158 0.041 DBMET03275 0.158 0.041 DBMET03276 | ||
| 0.237 | 0.121 | 0.237 | Ca(v)3.3 blocker | 0.237 0.121 DBMET03275 0.237 0.121 DBMET03276 | ||
| 0.133 | 0.018 | 0.133 | Keratolytic | 0.133 0.018 DBMET03275 0.133 0.018 DBMET03276 | ||
| 0.152 | 0.038 | 0.152 | Ca2+-transporting ATPase inhibitor | 0.152 0.038 DBMET03275 0.152 0.038 DBMET03276 | ||
| 0.166 | 0.051 | 0.166 | Cell wall synthesis inhibitor | 0.166 0.051 DBMET03275 0.166 0.051 DBMET03276 | ||
| 0.168 | 0.057 | 0.168 | NOS3 expression enhancer | 0.168 0.057 DBMET03275 0.168 0.057 DBMET03276 | ||
| 0.14 | 0.029 | 0.14 | HIV-1 integrase (Overall Integration) inhibitor | 0.14 0.029 DBMET03275 0.14 0.029 DBMET03276 | ||
| 0.148 | 0.038 | 0.148 | Ferrochelatase inhibitor | 0.148 0.038 DBMET03275 0.148 0.038 DBMET03276 | ||
| 0.145 | 0.036 | 0.145 | GABA C receptor agonist | 0.145 0.036 DBMET03275 0.145 0.036 DBMET03276 | ||
| 0.189 | 0.08 | 0.189 | Anesthetic general | 0.189 0.08 DBMET03275 0.189 0.08 DBMET03276 | ||
| 0.163 | 0.058 | 0.163 | GABA C receptor rho-2 antagonist | 0.163 0.058 DBMET03275 0.163 0.058 DBMET03276 | ||
| 0.151 | 0.047 | 0.151 | Cyclooxygenase 3 inhibitor | 0.151 0.047 DBMET03275 0.151 0.047 DBMET03276 | ||
| 0.11 | 0.011 | 0.11 | GABA B receptor agonist | 0.11 0.011 DBMET03275 0.11 0.011 DBMET03276 | ||
| 0.125 | 0.026 | 0.125 | Glutamate (mGluR7) agonist | 0.125 0.026 DBMET03275 0.125 0.026 DBMET03276 | ||
| 0.173 | 0.076 | 0.173 | Succinate dehydrogenase inhibitor | 0.173 0.076 DBMET03275 0.173 0.076 DBMET03276 | ||
| 0.117 | 0.024 | 0.117 | Glutamate release inhibitor | 0.117 0.024 DBMET03275 0.117 0.024 DBMET03276 | ||
| 0.13 | 0.039 | 0.13 | Mediator release inhibitor | 0.13 0.039 DBMET03275 0.13 0.039 DBMET03276 | ||
| 0.103 | 0.014 | 0.103 | Alpha 2 adrenoreceptor agonist | 0.103 0.014 DBMET03275 0.103 0.014 DBMET03276 | ||
| 0.106 | 0.018 | 0.106 | Estrogen-related receptor beta agonist | 0.106 0.018 DBMET03275 0.106 0.018 DBMET03276 | ||
| 0.14 | 0.052 | 0.14 | Proteasome inhibitor | 0.14 0.052 DBMET03275 0.14 0.052 DBMET03276 | ||
| 0.108 | 0.021 | 0.108 | D-Ala-D-Ala ligase inhibitor | 0.108 0.021 DBMET03275 0.108 0.021 DBMET03276 | ||
| 0.13 | 0.044 | 0.13 | GABA C receptor antagonist | 0.13 0.044 DBMET03275 0.13 0.044 DBMET03276 | ||
| 0.099 | 0.016 | 0.099 | Neuraminidase inhibitor | 0.099 0.016 DBMET03275 0.099 0.016 DBMET03276 | ||
| 0.125 | 0.041 | 0.125 | Carbonic anhydrase III inhibitor | 0.125 0.041 DBMET03275 0.125 0.041 DBMET03276 | ||
| 0.144 | 0.061 | 0.144 | Nav1.6 sodium channel blocker | 0.144 0.061 DBMET03275 0.144 0.061 DBMET03276 | ||
| 0.144 | 0.06 | 0.144 | Farnesoid X receptor antagonist | 0.144 0.06 DBMET03275 0.144 0.06 DBMET03276 | ||
| 0.113 | 0.031 | 0.113 | Ornithine decarboxylase inhibitor | 0.113 0.031 DBMET03275 0.113 0.031 DBMET03276 | ||
| 0.086 | 0.004 | 0.086 | Alpha 1d adrenoreceptor agonist | 0.086 0.004 DBMET03275 0.086 0.004 DBMET03276 | ||
| 0.131 | 0.05 | 0.131 | Cystathionine beta-synthase inhibitor | 0.131 0.05 DBMET03275 0.131 0.05 DBMET03276 | ||
| 0.097 | 0.018 | 0.097 | Maillard reaction inhibitor | 0.097 0.018 DBMET03275 0.097 0.018 DBMET03276 | ||
| 0.116 | 0.037 | 0.116 | Calcium antagonist | 0.116 0.037 DBMET03275 0.116 0.037 DBMET03276 | ||
| 0.105 | 0.028 | 0.105 | Nicotinic alpha4beta2 receptor antagonist | 0.105 0.028 DBMET03275 0.105 0.028 DBMET03276 | ||
| 0.121 | 0.046 | 0.121 | Carbonic anhydrase XV inhibitor | 0.121 0.046 DBMET03275 0.121 0.046 DBMET03276 | ||
| 0.09 | 0.015 | 0.09 | Heat shock protein 90 beta antagonist | 0.09 0.015 DBMET03275 0.09 0.015 DBMET03276 | ||
| 0.094 | 0.02 | 0.094 | Alcohol oxidase inhibitor | 0.094 0.02 DBMET03275 0.094 0.02 DBMET03276 | ||
| 0.16 | 0.087 | 0.16 | Nitric oxide antagonist | 0.16 0.087 DBMET03275 0.16 0.087 DBMET03276 | ||
| 0.157 | 0.085 | 0.157 | Neurotensin receptor agonist | 0.157 0.085 DBMET03275 0.157 0.085 DBMET03276 | ||
| 0.249 | 0.178 | 0.249 | Antibacterial | 0.249 0.178 DBMET03275 0.249 0.178 DBMET03276 | ||
| 0.09 | 0.02 | 0.09 | Neuraminidase (influenza) inhibitor | 0.09 0.02 DBMET03275 0.09 0.02 DBMET03276 | ||
| 0.116 | 0.047 | 0.116 | Adenylate kinase inhibitor | 0.116 0.047 DBMET03275 0.116 0.047 DBMET03276 | ||
| 0.121 | 0.053 | 0.121 | Estrogen antagonist | 0.121 0.053 DBMET03275 0.121 0.053 DBMET03276 | ||
| 0.112 | 0.043 | 0.112 | Estrogen receptor beta antagonist | 0.112 0.043 DBMET03275 0.112 0.043 DBMET03276 | ||
| 0.114 | 0.046 | 0.114 | GABA C receptor rho-1 antagonist | 0.114 0.046 DBMET03275 0.114 0.046 DBMET03276 | ||
| 0.142 | 0.074 | 0.142 | Protein kinase stimulant | 0.142 0.074 DBMET03275 0.142 0.074 DBMET03276 | ||
| 0.122 | 0.055 | 0.122 | Photosensitizer | 0.122 0.055 DBMET03275 0.122 0.055 DBMET03276 | ||
| 0.123 | 0.057 | 0.123 | Microtubule formation inhibitor | 0.123 0.057 DBMET03275 0.123 0.057 DBMET03276 | ||
| 0.132 | 0.069 | 0.132 | Sphingosine 1-phosphate receptor 2 antagonist | 0.132 0.069 DBMET03275 0.132 0.069 DBMET03276 | ||
| 0.098 | 0.035 | 0.098 | Somatostatin 1 agonist | 0.098 0.035 DBMET03275 0.098 0.035 DBMET03276 | ||
| 0.13 | 0.067 | 0.13 | Vanilloid 1 agonist | 0.13 0.067 DBMET03275 0.13 0.067 DBMET03276 | ||
| 0.186 | 0.123 | 0.186 | RNA-directed DNA polymerase inhibitor | 0.186 0.123 DBMET03275 0.186 0.123 DBMET03276 | ||
| 0.112 | 0.049 | 0.112 | UDP-glucose 4-epimerase inhibitor | 0.112 0.049 DBMET03275 0.112 0.049 DBMET03276 | ||
| 0.107 | 0.045 | 0.107 | Lanosterol 14 alpha demethylase inhibitor | 0.107 0.045 DBMET03275 0.107 0.045 DBMET03276 | ||
| 0.075 | 0.014 | 0.075 | Alpha-mannosidase inhibitor | 0.075 0.014 DBMET03275 0.075 0.014 DBMET03276 | ||
| 0.112 | 0.053 | 0.112 | Urease inhibitor | 0.112 0.053 DBMET03275 0.112 0.053 DBMET03276 | ||
| 0.066 | 0.008 | 0.066 | Diamine oxidase inhibitor | 0.066 0.008 DBMET03275 0.066 0.008 DBMET03276 | ||
| 0.099 | 0.043 | 0.099 | Interleukin 5 antagonist | 0.099 0.043 DBMET03275 0.099 0.043 DBMET03276 | ||
| 0.099 | 0.045 | 0.099 | NADH dehydrogenase inhibitor | 0.099 0.045 DBMET03275 0.099 0.045 DBMET03276 | ||
| 0.215 | 0.162 | 0.215 | Apoptosis antagonist | 0.215 0.162 DBMET03275 0.215 0.162 DBMET03276 | ||
| 0.153 | 0.101 | 0.153 | Phospholipase C inhibitor | 0.153 0.101 DBMET03275 0.153 0.101 DBMET03276 | ||
| 0.094 | 0.043 | 0.094 | Acetylcholine nicotinic antagonist | 0.094 0.043 DBMET03275 0.094 0.043 DBMET03276 | ||
| 0.103 | 0.052 | 0.103 | Prolactin inhibitor | 0.103 0.052 DBMET03275 0.103 0.052 DBMET03276 | ||
| 0.141 | 0.091 | 0.141 | Interferon gamma antagonist | 0.141 0.091 DBMET03275 0.141 0.091 DBMET03276 | ||
| 0.061 | 0.012 | 0.061 | Nicotinic receptor beta4 subunit antagonist | 0.061 0.012 DBMET03275 0.061 0.012 DBMET03276 | ||
| 0.144 | 0.095 | 0.144 | Arachidonic acid antagonist | 0.144 0.095 DBMET03275 0.144 0.095 DBMET03276 | ||
| 0.131 | 0.083 | 0.131 | Lipid peroxidase inhibitor | 0.131 0.083 DBMET03275 0.131 0.083 DBMET03276 | ||
| 0.064 | 0.016 | 0.064 | Alpha 1b adrenoreceptor agonist | 0.064 0.016 DBMET03275 0.064 0.016 DBMET03276 | ||
| 0.062 | 0.015 | 0.062 | Mannosidase inhibitor | 0.062 0.015 DBMET03275 0.062 0.015 DBMET03276 | ||
| 0.072 | 0.027 | 0.072 | Alpha 1 adrenoreceptor agonist | 0.072 0.027 DBMET03275 0.072 0.027 DBMET03276 | ||
| 0.083 | 0.039 | 0.083 | Aminopeptidase I inhibitor | 0.083 0.039 DBMET03275 0.083 0.039 DBMET03276 | ||
| 0.069 | 0.025 | 0.069 | Bombesin 3 receptor antagonist | 0.069 0.025 DBMET03275 0.069 0.025 DBMET03276 | ||
| 0.047 | 0.004 | 0.047 | Alpha 2a adrenoreceptor agonist | 0.047 0.004 DBMET03275 0.047 0.004 DBMET03276 | ||
| 0.08 | 0.037 | 0.08 | Secretase beta inhibitor | 0.08 0.037 DBMET03275 0.08 0.037 DBMET03276 | ||
| 0.119 | 0.078 | 0.119 | Toll-Like receptor 2 antagonist | 0.119 0.078 DBMET03275 0.119 0.078 DBMET03276 | ||
| 0.082 | 0.042 | 0.082 | Sphingosine 1-phosphate receptor antagonist | 0.082 0.042 DBMET03275 0.082 0.042 DBMET03276 | ||
| 0.132 | 0.093 | 0.132 | Hemostatic | 0.132 0.093 DBMET03275 0.132 0.093 DBMET03276 | ||
| 0.067 | 0.029 | 0.067 | Sphingosine 1-phosphate receptor 3 antagonist | 0.067 0.029 DBMET03275 0.067 0.029 DBMET03276 | ||
| 0.102 | 0.064 | 0.102 | Aminopeptidase B inhibitor | 0.102 0.064 DBMET03275 0.102 0.064 DBMET03276 | ||
| 0.053 | 0.015 | 0.053 | Dopamine D5 agonist | 0.053 0.015 DBMET03275 0.053 0.015 DBMET03276 | ||
| 0.121 | 0.085 | 0.121 | Bone formation stimulant | 0.121 0.085 DBMET03275 0.121 0.085 DBMET03276 | ||
| 0.069 | 0.032 | 0.069 | Acetylcholine M5 receptor antagonist | 0.069 0.032 DBMET03275 0.069 0.032 DBMET03276 | ||
| 0.137 | 0.101 | 0.137 | CF transmembrane conductance regulator agonist | 0.137 0.101 DBMET03275 0.137 0.101 DBMET03276 | ||
| 0.04 | 0.007 | 0.04 | Alpha 1a adrenoreceptor agonist | 0.04 0.007 DBMET03275 0.04 0.007 DBMET03276 | ||
| 0.07 | 0.037 | 0.07 | Acetylcholine M2 receptor antagonist | 0.07 0.037 DBMET03275 0.07 0.037 DBMET03276 | ||
| 0.039 | 0.007 | 0.039 | Purinergic P2Y15 antagonist | 0.039 0.007 DBMET03275 0.039 0.007 DBMET03276 | ||
| 0.091 | 0.059 | 0.091 | Triose-phosphate isomerase inhibitor | 0.091 0.059 DBMET03275 0.091 0.059 DBMET03276 | ||
| 0.095 | 0.063 | 0.095 | Phosphodiesterase 6D inhibitor | 0.095 0.063 DBMET03275 0.095 0.063 DBMET03276 | ||
| 0.036 | 0.005 | 0.036 | 1,3-Beta-glucan synthase inhibitor | 0.036 0.005 DBMET03275 0.036 0.005 DBMET03276 | ||
| 0.111 | 0.081 | 0.111 | Aldehyde dehydrogenase inhibitor | 0.111 0.081 DBMET03275 0.111 0.081 DBMET03276 | ||
| 0.05 | 0.021 | 0.05 | HIV-1 protease inhibitor | 0.05 0.021 DBMET03275 0.05 0.021 DBMET03276 | ||
| 0.059 | 0.032 | 0.059 | Pregnane X receptor antagonist | 0.059 0.032 DBMET03275 0.059 0.032 DBMET03276 | ||
| 0.065 | 0.038 | 0.065 | Carbamoyl phosphate synthetase inhibitor | 0.065 0.038 DBMET03275 0.065 0.038 DBMET03276 | ||
| 0.081 | 0.055 | 0.081 | Carbonic anhydrase VI inhibitor | 0.081 0.055 DBMET03275 0.081 0.055 DBMET03276 | ||
| 0.106 | 0.081 | 0.106 | Alkylator | 0.106 0.081 DBMET03275 0.106 0.081 DBMET03276 | ||
| 0.046 | 0.021 | 0.046 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.046 0.021 DBMET03275 0.046 0.021 DBMET03276 | ||
| 0.068 | 0.043 | 0.068 | Glutamate (mGluR6) antagonist | 0.068 0.043 DBMET03275 0.068 0.043 DBMET03276 | ||
| 0.104 | 0.079 | 0.104 | CDK3/cyclin E inhibitor | 0.104 0.079 DBMET03275 0.104 0.079 DBMET03276 | ||
| 0.124 | 0.1 | 0.124 | Diuretic | 0.124 0.1 DBMET03275 0.124 0.1 DBMET03276 | ||
| 0.077 | 0.053 | 0.077 | Na+ K+ transporting ATPase inhibitor | 0.077 0.053 DBMET03275 0.077 0.053 DBMET03276 | ||
| 0.057 | 0.034 | 0.057 | Sphingosine 1-phosphate receptor 1 antagonist | 0.057 0.034 DBMET03275 0.057 0.034 DBMET03276 | ||
| 0.063 | 0.041 | 0.063 | NMDA 2C receptor antagonist | 0.063 0.041 DBMET03275 0.063 0.041 DBMET03276 | ||
| 0.032 | 0.011 | 0.032 | Sodium/glucose cotransporter 2 inhibitor | 0.032 0.011 DBMET03275 0.032 0.011 DBMET03276 | ||
| 0.073 | 0.053 | 0.073 | Porphobilinogen synthase inhibitor | 0.073 0.053 DBMET03275 0.073 0.053 DBMET03276 | ||
| 0.031 | 0.01 | 0.031 | Sodium/glucose cotransporter inhibitor | 0.031 0.01 DBMET03275 0.031 0.01 DBMET03276 | ||
| 0.025 | 0.006 | 0.025 | Ileal bile acid transport inhibitor | 0.025 0.006 DBMET03275 0.025 0.006 DBMET03276 | ||
| 0.068 | 0.049 | 0.068 | Phosphofructokinase-1 inhibitor | 0.068 0.049 DBMET03275 0.068 0.049 DBMET03276 | ||
| 0.054 | 0.036 | 0.054 | Nicotinic alpha3beta2 receptor antagonist | 0.054 0.036 DBMET03275 0.054 0.036 DBMET03276 | ||
| 0.107 | 0.089 | 0.107 | Transcription factor STAT6 inhibitor | 0.107 0.089 DBMET03275 0.107 0.089 DBMET03276 | ||
| 0.081 | 0.065 | 0.081 | Androgen antagonist | 0.081 0.065 DBMET03275 0.081 0.065 DBMET03276 | ||
| 0.037 | 0.022 | 0.037 | Ceramide glucosyltransferase inhibitor | 0.037 0.022 DBMET03275 0.037 0.022 DBMET03276 | ||
| 0.089 | 0.075 | 0.089 | Bile acid receptor antagonist | 0.089 0.075 DBMET03275 0.089 0.075 DBMET03276 | ||
| 0.053 | 0.039 | 0.053 | Acyl-CoA dehydrogenase inhibitor | 0.053 0.039 DBMET03275 0.053 0.039 DBMET03276 | ||
| 0.063 | 0.05 | 0.063 | Purinergic P2X2 antagonist | 0.063 0.05 DBMET03275 0.063 0.05 DBMET03276 | ||
| 0.137 | 0.124 | 0.137 | Hepatoprotectant | 0.137 0.124 DBMET03275 0.137 0.124 DBMET03276 | ||
| 0.096 | 0.083 | 0.096 | Nav1.4 sodium channel blocker | 0.096 0.083 DBMET03275 0.096 0.083 DBMET03276 | ||
| 0.057 | 0.045 | 0.057 | Androgen agonist | 0.057 0.045 DBMET03275 0.057 0.045 DBMET03276 | ||
| 0.023 | 0.011 | 0.023 | Neuraminidase (Influenza B) inhibitor | 0.023 0.011 DBMET03275 0.023 0.011 DBMET03276 | ||
| 0.084 | 0.073 | 0.084 | Polo-like kinase-1 inhibitor | 0.084 0.073 DBMET03275 0.084 0.073 DBMET03276 | ||
| 0.087 | 0.076 | 0.087 | Toll-Like receptor 3 antagonist | 0.087 0.076 DBMET03275 0.087 0.076 DBMET03276 | ||
| 0.063 | 0.051 | 0.063 | Sphingosine 1-phosphate receptor 4 agonist | 0.063 0.051 DBMET03275 0.063 0.051 DBMET03276 | ||
| 0.098 | 0.088 | 0.098 | DNA polymerase I inhibitor | 0.098 0.088 DBMET03275 0.098 0.088 DBMET03276 | ||
| 0.069 | 0.058 | 0.069 | Glutamate dehydrogenase inhibitor | 0.069 0.058 DBMET03275 0.069 0.058 DBMET03276 | ||
| 0.049 | 0.038 | 0.049 | Lysophosphatidic acid 3 receptor antagonist | 0.049 0.038 DBMET03275 0.049 0.038 DBMET03276 | ||
| 0.133 | 0.122 | 0.133 | Amyloid beta aggregation inhibitor | 0.133 0.122 DBMET03275 0.133 0.122 DBMET03276 | ||
| 0.049 | 0.039 | 0.049 | Factor IXa inhibitor | 0.049 0.039 DBMET03275 0.049 0.039 DBMET03276 | ||
| 0.067 | 0.057 | 0.067 | Catalase inhibitor | 0.067 0.057 DBMET03275 0.067 0.057 DBMET03276 | ||
| 0.124 | 0.115 | 0.124 | Sphingosine 1-phosphate receptor 5 antagonist | 0.124 0.115 DBMET03275 0.124 0.115 DBMET03276 | ||
| 0.034 | 0.025 | 0.034 | Phosphoglycerate kinase inhibitor | 0.034 0.025 DBMET03275 0.034 0.025 DBMET03276 | ||
| 0.074 | 0.066 | 0.074 | MAP kinase kinase 7 inhibitor | 0.074 0.066 DBMET03275 0.074 0.066 DBMET03276 | ||
| 0.095 | 0.088 | 0.095 | Interleukin 1b antagonist | 0.095 0.088 DBMET03275 0.095 0.088 DBMET03276 | ||
| 0.077 | 0.07 | 0.077 | Alpha 2 adrenoreceptor antagonist | 0.077 0.07 DBMET03275 0.077 0.07 DBMET03276 | ||
| 0.046 | 0.04 | 0.046 | Potassium channel (Inward rectifier) blocker | 0.046 0.04 DBMET03275 0.046 0.04 DBMET03276 | ||
| 0.081 | 0.078 | 0.081 | Alcohol dehydrogenase inhibitor | 0.081 0.078 DBMET03275 0.081 0.078 DBMET03276 | ||
| 0.024 | 0.021 | 0.024 | Vanilloid 2 agonist | 0.024 0.021 DBMET03275 0.024 0.021 DBMET03276 | ||
| 0.04 | 0.038 | 0.04 | Geranyltranstransferase inhibitor | 0.04 0.038 DBMET03275 0.04 0.038 DBMET03276 | ||
| 0.029 | 0.027 | 0.029 | Estrogen receptor alpha agonist | 0.029 0.027 DBMET03275 0.029 0.027 DBMET03276 | ||
| 0.05 | 0.048 | 0.05 | Sphingosine kinase 2 inhibitor | 0.05 0.048 DBMET03275 0.05 0.048 DBMET03276 | ||
| 0.045 | 0.043 | 0.045 | NMDA 2A receptor antagonist | 0.045 0.043 DBMET03275 0.045 0.043 DBMET03276 | ||
| 0.03 | 0.028 | 0.03 | Catechol O-methyltransferase inhibitor | 0.03 0.028 DBMET03275 0.03 0.028 DBMET03276 | ||
| 0.105 | 0.104 | 0.105 | Nav1.2 sodium channel blocker | 0.105 0.104 DBMET03275 0.105 0.104 DBMET03276 | ||
| 0.05 | 0.049 | 0.05 | Dopamine uptake inhibitor | 0.05 0.049 DBMET03275 0.05 0.049 DBMET03276 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |